Cargando…
Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
INTRODUCTION: Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906175/ https://www.ncbi.nlm.nih.gov/pubmed/36746540 http://dx.doi.org/10.1136/bmjopen-2022-068122 |
_version_ | 1784883949249495040 |
---|---|
author | Bratti, Vanessa F Wilson, Brooke E Fazelzad, Rouhi Pabani, Aliyah Zurn, Shalini J Johnson, Sonali Sung, Lillian Rodin, Danielle |
author_facet | Bratti, Vanessa F Wilson, Brooke E Fazelzad, Rouhi Pabani, Aliyah Zurn, Shalini J Johnson, Sonali Sung, Lillian Rodin, Danielle |
author_sort | Bratti, Vanessa F |
collection | PubMed |
description | INTRODUCTION: Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibiotics increases the risk of AMR. Failure to adequately prevent and treat infection in patients with cancer as a result of AMR can increase the morbidity and mortality of the disease. The objective of this scoping review is to understand the relationship between AMR and cancer in order to develop effective antimicrobial stewardship in this patient population and minimise the detrimental effects of AMR on cancer outcomes. METHODS AND ANALYSIS: This scoping review will follow the Arksey and O’Malley methodology framework. An exploratory review of the literature on antibiotic resistance in cancer care will help to define the research questions (stage 1). A broad range of electronic databases (MEDLINE ALL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Embase) and search terms will be used to retrieve relevant articles published between 2000 and 2021 (stage 2). Studies will be systematically selected based on the eligibility criteria by two independent reviewers (stage 3). The titles and abstracts will be appraised to determine whether articles meet the eligibility criteria. This will be followed by screening of the full texts and only relevant publications will be retrieved. Data will then be extracted, collated and charted (stage 4); and the summary of aggregated results will be presented (stage 5). ETHICS AND DISSEMINATION: As this scoping review will collect and synthesise data from publicly available sources, no ethics review is required. When data collection and summarisation is completed, results will be disseminated through peer-reviewed publication and the key findings of the review will be presented at relevant conferences. |
format | Online Article Text |
id | pubmed-9906175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-99061752023-02-08 Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes Bratti, Vanessa F Wilson, Brooke E Fazelzad, Rouhi Pabani, Aliyah Zurn, Shalini J Johnson, Sonali Sung, Lillian Rodin, Danielle BMJ Open Global Health INTRODUCTION: Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibiotics increases the risk of AMR. Failure to adequately prevent and treat infection in patients with cancer as a result of AMR can increase the morbidity and mortality of the disease. The objective of this scoping review is to understand the relationship between AMR and cancer in order to develop effective antimicrobial stewardship in this patient population and minimise the detrimental effects of AMR on cancer outcomes. METHODS AND ANALYSIS: This scoping review will follow the Arksey and O’Malley methodology framework. An exploratory review of the literature on antibiotic resistance in cancer care will help to define the research questions (stage 1). A broad range of electronic databases (MEDLINE ALL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Embase) and search terms will be used to retrieve relevant articles published between 2000 and 2021 (stage 2). Studies will be systematically selected based on the eligibility criteria by two independent reviewers (stage 3). The titles and abstracts will be appraised to determine whether articles meet the eligibility criteria. This will be followed by screening of the full texts and only relevant publications will be retrieved. Data will then be extracted, collated and charted (stage 4); and the summary of aggregated results will be presented (stage 5). ETHICS AND DISSEMINATION: As this scoping review will collect and synthesise data from publicly available sources, no ethics review is required. When data collection and summarisation is completed, results will be disseminated through peer-reviewed publication and the key findings of the review will be presented at relevant conferences. BMJ Publishing Group 2023-02-06 /pmc/articles/PMC9906175/ /pubmed/36746540 http://dx.doi.org/10.1136/bmjopen-2022-068122 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Global Health Bratti, Vanessa F Wilson, Brooke E Fazelzad, Rouhi Pabani, Aliyah Zurn, Shalini J Johnson, Sonali Sung, Lillian Rodin, Danielle Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes |
title | Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes |
title_full | Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes |
title_fullStr | Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes |
title_full_unstemmed | Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes |
title_short | Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes |
title_sort | scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes |
topic | Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906175/ https://www.ncbi.nlm.nih.gov/pubmed/36746540 http://dx.doi.org/10.1136/bmjopen-2022-068122 |
work_keys_str_mv | AT brattivanessaf scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes AT wilsonbrookee scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes AT fazelzadrouhi scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes AT pabanialiyah scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes AT zurnshalinij scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes AT johnsonsonali scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes AT sunglillian scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes AT rodindanielle scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes |